KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Oct 01, 2026 - 3:59PM >>  ABB India 6854.4  [ 1.49% ]  ACC 1182.2  [ -1.86% ]  Ambuja Cements 363  [ -2.46% ]  Asian Paints 2406.25  [ -0.29% ]  Axis Bank 1214  [ -0.98% ]  Bajaj Auto 10069.85  [ -7.28% ]  Bank of Baroda 231.75  [ 0.32% ]  Bharti Airtel 1741  [ -0.98% ]  Bharat Heavy 422  [ 1.69% ]  Bharat Petroleum 301  [ -0.66% ]  Britannia Industries 4794.85  [ -0.33% ]  Cipla 1346.85  [ -0.23% ]  Coal India 421.5  [ -0.67% ]  Colgate Palm 1735  [ -2.20% ]  Dabur India 377  [ -1.05% ]  DLF 662.6  [ -1.40% ]  Dr. Reddy's Lab. 1200.1  [ -2.90% ]  GAIL (India) 170.8  [ 0.06% ]  Grasim Industries 2971.85  [ -3.12% ]  HCL Technologies 1246  [ 1.38% ]  HDFC Bank 719.35  [ 1.36% ]  Hero MotoCorp 5173  [ -1.22% ]  Hindustan Unilever 1841  [ -2.17% ]  Hindalco Industries 944.4  [ 0.22% ]  ICICI Bank 1305.5  [ -1.29% ]  Indian Hotels Co. 716.15  [ -1.76% ]  IndusInd Bank 880  [ -1.97% ]  Infosys 1035  [ 4.02% ]  ITC 257  [ -2.56% ]  Jindal Steel 1099  [ -2.92% ]  Kotak Mahindra Bank 419.8  [ 0.53% ]  L&T 3685.5  [ -1.85% ]  Lupin 2029  [ -0.64% ]  Mahi. & Mahi 2851.05  [ -3.27% ]  Maruti Suzuki India 11400  [ -4.59% ]  MTNL 24.7  [ 7.30% ]  Nestle India 1303.8  [ -0.63% ]  NIIT 85.25  [ -0.70% ]  NMDC 75  [ -2.33% ]  NTPC 316.7  [ -1.65% ]  ONGC 222.7  [ -1.02% ]  Punj. NationlBak 109.9  [ -3.09% ]  Power Grid Corpn. 254.65  [ -2.23% ]  Reliance Industries 1166  [ -1.81% ]  SBI 954  [ -0.70% ]  Vedanta 251.9  [ -2.70% ]  Shipping Corpn. 267.15  [ -1.24% ]  Sun Pharmaceutical 1810  [ -0.55% ]  Tata Chemicals 607.9  [ -0.54% ]  Tata Consumer 949  [ -0.42% ]  Tata Motors Passenge 280  [ -1.70% ]  Tata Steel 179.1  [ -3.01% ]  Tata Power Co. 350  [ -2.51% ]  Tata Consult. Serv. 2079.3  [ 1.43% ]  Tech Mahindra 1539  [ 0.40% ]  UltraTech Cement 10799  [ -1.60% ]  United Spirits 1338.2  [ -0.87% ]  Wipro 159.5  [ 0.69% ]  Zee Entertainment 71.9  [ -3.48% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

BRAWN BIOTECH LTD.

01 October 2026 | 04:01

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE899B01015 BSE Code / NSE Code 530207 / BRAWN Book Value (Rs.) 14.98 Face Value 10.00
Bookclosure 18/09/2023 52Week High 25 EPS 3.14 P/E 7.85
Market Cap. 7.38 Cr. 52Week Low 18 P/BV / Div Yield (%) 1.64 / 0.00 Market Lot 1.00
Security Type Other

NOTES TO ACCOUNTS

You can view the entire text of Notes to accounts of the company for the latest year
Year End :2025-03 

IX. Provisions, Contingent Liabilities and Contingent Assets:

Provisions are recognized when the Company has a present obligation as a result of past events and it is probable that the
outflow of resources will be required to settle the obligation and in respect of which reliable estimates can be made. A
disclosure for contingent liability is made when there is a possible obligation that may, but probably will not require an outflow
of resources. When there is a possible obligation or a present obligation in respect of which the likelihood of outflow of
resources is remote, no provision/disclosure is made. Provision and contingencies are reviewed at each balance sheet date
and adjusted to reflect the correct management estimates. Contingent assets are not recognized but are disclosed separately
in financial statements.

X. Employees Benefits:

Liability for gratuity and leave encashment is being provided based upon the certificate of Actuary at the end of the year.

XI. Financial Instruments:

A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity
instrument of another entity.

Financial assets

Financial assets include cash and cash equivalents, trade and other receivables, investments in securities and other eligible
current and non-current assets.

At initial recognition, all financial assets are measured at fair value. Such financial assets are subsequently classified under
one of the following three categories according to the purpose for which they are held. The classification is reviewed at the end
of each reporting period.

Financial Assets at Amortized Cost: - At the date of initial recognition, financial assets are held to collect contractual cash
flows of principal and interest on principal amount outstanding on specified dates. These financial assets are intended to be held
until maturity. Therefore, they are subsequently measured at amortized cost by applying the Effective Interest Rate (EIR) method
to the gross carrying amount of the financial asset. The EIR amortization is included as interest income in the profit or loss. The
losses arising from impairment are recognized in the profit or loss.

Financial Assets at Fair value through Other Comprehensive Income: - At the date of initial recognition, financial assets
are held to collect contractual cash flows of principal and interest on principal amount outstanding on specified dates, as well
as held for selling. Therefore, they are subsequently measured at each reporting date at fair value, with all fair value
movements recognized in Other Comprehensive Income (OCI). Interest income calculated using the effective interest rate
(EIR) method, impairment gain or loss and foreign exchange gain or loss are recognized in the Statement of Profit and Loss.
On de-recognition of the asset, cumulative gain or loss previously recognized in Other Comprehensive Income is reclassified
from the OCI to Statement of Profit and Loss.

Financial Assets at Fair value through Profit or Loss: - At the date of initial recognition, financial assets are held for trading, or
which are measured neither at Amortized Cost nor at Fair Value through OCI. Therefore, they are subsequently measured at each
reporting date at fair value, with all fair value movements recognized in the Statement of Profit and Loss.

The Company derecognizes a financial asset when the contractual rights to the cash flows from the financial asset expire or it
transfers the financial asset and the transfer qualifies for De recognition under Ind AS 109.

Financial Liabilities

Financial liabilities include long-term and short-term loans and borrowings, trade and other payables and other eligible current
and non-current liabilities.

All financial liabilities are recognized initially at fair value and, in the case of loans and borrowings and other payables, net of
directly attributable transaction costs. After ini ignition, financial liabilities are classified under one of the following two
categories

Financial Liabilities at Amortized Cost After initial recognition, such financial liabilities are subsequently
measured at amortized cost by applying the Effective Interest Rate (EIR) method to the gross carrying amount of the
financial liability. The EIR amortization is included in finance expense in the profit or loss.

Financial liabilities at Fair Value through Profit or Loss - which are designated as such on initial recognition, or which
are held for trading. Fair value gains/ losses attributable to changes in own credit risk is recognized in OCI. These gains/
loss are not subsequently transferred to Statement of Profit and Loss. All other changes in fair value of such liabilities
are recognized in the Statement of Profit and Loss.

The Company recognizes a financial liability when the obligation specified in the contract is discharged, cancelled
or expires.

Note:2- Notes to Accounts

VI. Segment Reporting (Ind-AS-108)

The identification of Business segment is done in accordance with the system adopted for internal financial reporting to
the board of directors and management structure. The company deals only in Pharmaceutical product which in the
context of Ind-AS 108 is considered the only primary business segment. Hence no segmental reporting is required.

X. Dividend to Shareholders

Annual dividend distribution to the shareholders is recognized as a liability in the period in which the dividends are
approved by the shareholders. Any interim dividend paid is recognized on approval by Board of Directors. Dividend
payable and corresponding tax on dividend distribution is recognized directly in equity.

XI. Terms/Rights attached to equity shares

The company has only one class of equity shares with voting rights having a par value of Rs. 10 per share. The company
declares & pays dividend in Indian Rupees. Any interim dividend paid is recognized on the approval by Board of Directors.
During the year ended 31st March 2025, the amount of dividend per equity share recognized as distribution to equity
shareholders s Nil (Pr. Year Nil), which includes interim dividend of Nil (Pr. Year Nil) per equity share,

In the event of liquidation of the company, the holders of equity shares will be entitled to receive remaining assets of
the company, after distribution of all preferential amounts. The distribution will be in proportion to the numbers of
equity shares held by shareholders.

The reason for variance

($) Due to significant increase in the value of closing stock.

(#) Due to increase in trade payables during the year.

(@) Due to increase in working capital at the year end.

XVII. Previous year's figures have been regrouped/rearranged wherever necessary to make
them comparable with current year figures.

For Rajiv Udai & Associates For and on behalf of Board of Directors

Chartered Accountants

Firm Registration No. 018764N

Sd/- Sd/-

Brij Raj Gupta Pooja Jha

Sd/- (Director) (Director)

Rajeev Jain DIN No. 00974969 DIN No. 10749145

Partner

M.No.099767

UDIN:25099767BMIVFZ6120

Sd/- Sd/-

Place: Delhi Pooja Pandey Priyanka Sharma

Date: 26-05-2025 (Chief Financial Officer) (Company Secretary)